423 related articles for article (PubMed ID: 25479696)
1. 40-year trends in an index of survival for all cancers combined and survival adjusted for age and sex for each cancer in England and Wales, 1971-2011: a population-based study.
Quaresma M; Coleman MP; Rachet B
Lancet; 2015 Mar; 385(9974):1206-18. PubMed ID: 25479696
[TBL] [Abstract][Full Text] [Related]
2. Population-based cancer survival trends in England and Wales up to 2007: an assessment of the NHS cancer plan for England.
Rachet B; Maringe C; Nur U; Quaresma M; Shah A; Woods LM; Ellis L; Walters S; Forman D; Steward J; Coleman MP
Lancet Oncol; 2009 Apr; 10(4):351-69. PubMed ID: 19303813
[TBL] [Abstract][Full Text] [Related]
3. Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data.
Coleman MP; Forman D; Bryant H; Butler J; Rachet B; Maringe C; Nur U; Tracey E; Coory M; Hatcher J; McGahan CE; Turner D; Marrett L; Gjerstorff ML; Johannesen TB; Adolfsson J; Lambe M; Lawrence G; Meechan D; Morris EJ; Middleton R; Steward J; Richards MA;
Lancet; 2011 Jan; 377(9760):127-38. PubMed ID: 21183212
[TBL] [Abstract][Full Text] [Related]
4. Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2).
Allemani C; Weir HK; Carreira H; Harewood R; Spika D; Wang XS; Bannon F; Ahn JV; Johnson CJ; Bonaventure A; Marcos-Gragera R; Stiller C; Azevedo e Silva G; Chen WQ; Ogunbiyi OJ; Rachet B; Soeberg MJ; You H; Matsuda T; Bielska-Lasota M; Storm H; Tucker TC; Coleman MP;
Lancet; 2015 Mar; 385(9972):977-1010. PubMed ID: 25467588
[TBL] [Abstract][Full Text] [Related]
5. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
6. Cancer incidence, treatment, and survival in the prison population compared with the general population in England: a population-based, matched cohort study.
Lüchtenborg M; Huynh J; Armes J; Plugge E; Hunter RM; Visser R; Taylor RM; Davies EA
Lancet Oncol; 2024 May; 25(5):553-562. PubMed ID: 38697154
[TBL] [Abstract][Full Text] [Related]
7. Progress in cancer survival, mortality, and incidence in seven high-income countries 1995-2014 (ICBP SURVMARK-2): a population-based study.
Arnold M; Rutherford MJ; Bardot A; Ferlay J; Andersson TM; Myklebust TÅ; Tervonen H; Thursfield V; Ransom D; Shack L; Woods RR; Turner D; Leonfellner S; Ryan S; Saint-Jacques N; De P; McClure C; Ramanakumar AV; Stuart-Panko H; Engholm G; Walsh PM; Jackson C; Vernon S; Morgan E; Gavin A; Morrison DS; Huws DW; Porter G; Butler J; Bryant H; Currow DC; Hiom S; Parkin DM; Sasieni P; Lambert PC; Møller B; Soerjomataram I; Bray F
Lancet Oncol; 2019 Nov; 20(11):1493-1505. PubMed ID: 31521509
[TBL] [Abstract][Full Text] [Related]
8. Socioeconomic inequalities in cancer survival in England and Wales.
Coleman MP; Babb P; Sloggett A; Quinn M; De Stavola B
Cancer; 2001 Jan; 91(1 Suppl):208-16. PubMed ID: 11148581
[TBL] [Abstract][Full Text] [Related]
9. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
10. Trends in oesophageal and gastric cancer incidence, mortality and survival in England and Wales 1971-1998/1999.
Newnham A; Quinn MJ; Babb P; Kang JY; Majeed A
Aliment Pharmacol Ther; 2003 Mar; 17(5):655-64. PubMed ID: 12641514
[TBL] [Abstract][Full Text] [Related]
11. Incidence and mortality of primary liver cancer in England and Wales: changing patterns and ethnic variations.
Ladep NG; Khan SA; Crossey MM; Thillainayagam AV; Taylor-Robinson SD; Toledano MB
World J Gastroenterol; 2014 Feb; 20(6):1544-53. PubMed ID: 24587630
[TBL] [Abstract][Full Text] [Related]
12. Cancer survival in England and Wales at the end of the 20th century.
Rachet B; Woods LM; Mitry E; Riga M; Cooper N; Quinn MJ; Steward J; Brenner H; Estève J; Sullivan R; Coleman MP
Br J Cancer; 2008 Sep; 99 Suppl 1(Suppl 1):S2-10. PubMed ID: 18813248
[TBL] [Abstract][Full Text] [Related]
13. Risk of subsequent primary neoplasms in survivors of adolescent and young adult cancer (Teenage and Young Adult Cancer Survivor Study): a population-based, cohort study.
Bright CJ; Reulen RC; Winter DL; Stark DP; McCabe MG; Edgar AB; Frobisher C; Hawkins MM
Lancet Oncol; 2019 Apr; 20(4):531-545. PubMed ID: 30797674
[TBL] [Abstract][Full Text] [Related]
14. Worldwide comparison of survival from childhood leukaemia for 1995-2009, by subtype, age, and sex (CONCORD-2): a population-based study of individual data for 89 828 children from 198 registries in 53 countries.
Bonaventure A; Harewood R; Stiller CA; Gatta G; Clavel J; Stefan DC; Carreira H; Spika D; Marcos-Gragera R; Peris-Bonet R; Piñeros M; Sant M; Kuehni CE; Murphy MFG; Coleman MP; Allemani C;
Lancet Haematol; 2017 May; 4(5):e202-e217. PubMed ID: 28411119
[TBL] [Abstract][Full Text] [Related]
15. Trends and socioeconomic inequalities in cancer survival in England and Wales up to 2001.
Coleman MP; Rachet B; Woods LM; Mitry E; Riga M; Cooper N; Quinn MJ; Brenner H; Estève J
Br J Cancer; 2004 Apr; 90(7):1367-73. PubMed ID: 15054456
[TBL] [Abstract][Full Text] [Related]
16. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
17. Trends in testicular carcinoma in England and Wales, 1971-99.
Power DA; Brown RS; Brock CS; Payne HA; Majeed A; Babb P
BJU Int; 2001 Mar; 87(4):361-5. PubMed ID: 11251531
[TBL] [Abstract][Full Text] [Related]
18. Changing cancer survival in China during 2003-15: a pooled analysis of 17 population-based cancer registries.
Zeng H; Chen W; Zheng R; Zhang S; Ji JS; Zou X; Xia C; Sun K; Yang Z; Li H; Wang N; Han R; Liu S; Li H; Mu H; He Y; Xu Y; Fu Z; Zhou Y; Jiang J; Yang Y; Chen J; Wei K; Fan D; Wang J; Fu F; Zhao D; Song G; Chen J; Jiang C; Zhou X; Gu X; Jin F; Li Q; Li Y; Wu T; Yan C; Dong J; Hua Z; Baade P; Bray F; Jemal A; Yu XQ; He J
Lancet Glob Health; 2018 May; 6(5):e555-e567. PubMed ID: 29653628
[TBL] [Abstract][Full Text] [Related]
19. Cancer survival in five continents: a worldwide population-based study (CONCORD).
Coleman MP; Quaresma M; Berrino F; Lutz JM; De Angelis R; Capocaccia R; Baili P; Rachet B; Gatta G; Hakulinen T; Micheli A; Sant M; Weir HK; Elwood JM; Tsukuma H; Koifman S; E Silva GA; Francisci S; Santaquilani M; Verdecchia A; Storm HH; Young JL;
Lancet Oncol; 2008 Aug; 9(8):730-56. PubMed ID: 18639491
[TBL] [Abstract][Full Text] [Related]
20. Heparin versus citrate anticoagulation for continuous renal replacement therapy in intensive care: the RRAM observational study.
Gould DW; Doidge J; Sadique MZ; Borthwick M; Hatch R; Caskey FJ; Forni L; Lawrence RF; MacEwen C; Ostermann M; Mouncey PR; Harrison DA; Rowan KM; Young JD; Watkinson PJ
Health Technol Assess; 2022 Feb; 26(13):1-58. PubMed ID: 35212260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
